Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ductal Carcinoma in Situ of the Breast”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT03909282
What this trial is testing

Surgical Excision vs Neoadjuvant Radiotherapy+Delayed Surgical Excision of Ductal Carcinoma

Who this might be right for
Ductal Breast Carcinoma in Situ
Stanford University 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT04176081
What this trial is testing

Study of Radiation Therapy in Combination With Darolutamide + Degarelix in Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University Health Network, Toronto 208
Not applicableStudy completedNCT03375892
What this trial is testing

The Use of Deep Inspiration Breath Hold and Prone Irradiation to Decrease Cardiac Radiation Exposure

Who this might be right for
Breast CancerDuctal Carcinoma in SituInvasive Breast Cancer
Medical College of Wisconsin 11
Not applicableUnknownNCT00126464
What this trial is testing

Fulvestrant or Tamoxifen in Treating Postmenopausal Women Who Are Undergoing Surgery for Ductal Carcinoma in Situ of the Breast

Who this might be right for
Breast Cancer
Cedars-Sinai Medical Center 100
Testing effectiveness (Phase 2)Study completedNCT03703492
What this trial is testing

Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS

Who this might be right for
Breast CancerDuctal Carcinoma in Situ - Category
University of Wisconsin, Madison 12
Testing effectiveness (Phase 2)Study completedNCT01869764
What this trial is testing

Omega-3 Fatty Acid in Treating Patients With Stage I-III Breast Cancer

Who this might be right for
Ductal Breast Carcinoma in SituLobular Breast Carcinoma in SituMale Breast Cancer+6 more
Wake Forest University Health Sciences 57
Not applicableUnknownNCT04052893
What this trial is testing

DFS and QOL After Modified Radical Mastectomy vs. Expanded Mckissock Surgery for EIC of the Breast

Who this might be right for
Breast Neoplasms
Shengjing Hospital 200
Testing effectiveness (Phase 2)Study completedNCT01439711
What this trial is testing

Letrozole in Treating Postmenopausal Women With Ductal Carcinoma in Situ

Who this might be right for
Breast Cancer
Alliance for Clinical Trials in Oncology 108
Early research (Phase 1)Not Yet RecruitingNCT07408856
What this trial is testing

CAN1012 in Pre-Malignant DCIS and LCIS

Who this might be right for
Ductal Carcinoma in SituLobular Carcinoma in Situ
Providence Health & Services 24
Early research (Phase 1)Study completedNCT00028496
What this trial is testing

Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the GallbladderAdenocarcinoma of the Pancreas+39 more
National Cancer Institute (NCI) 48
Early research (Phase 1)Ended earlyNCT02876640
What this trial is testing

Retinoid 9cUAB30 in Producing a Biologic Effect in Patients With Early Stage Breast Cancer

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+6 more
National Cancer Institute (NCI) 27
Not applicableActive Not RecruitingNCT05410951
What this trial is testing

LobularCard Trial: Searching for Novel Germline Mutations in Lobular Breast Cancer Patients

Who this might be right for
Lobular Breast CarcinomaLobular in Situ Breast CarcinomaBRCA1 Mutation+1 more
European Institute of Oncology 800
Testing effectiveness (Phase 2)Looking for participantsNCT06184750
What this trial is testing

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

Who this might be right for
Breast Atypical Ductal HyperplasiaBreast Atypical Lobular HyperplasiaBreast Carcinoma+3 more
National Cancer Institute (NCI) 200
Not applicableActive Not RecruitingNCT03216421
What this trial is testing

Intraoperative Radiation Therapy (IORT) in DCIS

Who this might be right for
Breast CancerDuctal Carcinoma in Situ
Columbia University 265
Not applicableStudy completedNCT06133647
What this trial is testing

Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System

Who this might be right for
Ductal Carcinoma in SituInvasive Lobular Breast Carcinoma
Methodist Health System 8
Large-scale testing (Phase 3)Looking for participantsNCT01185132
What this trial is testing

Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy

Who this might be right for
Breast Cancer
Rocky Mountain Cancer Centers 660
Not applicableStudy completedNCT00380952
What this trial is testing

Intraoperative Use of the BP Device for Detecting Positive Margins During Lumpectomy Procedure

Who this might be right for
Breast Cancer
Dune Medical Devices 300
Not applicableUnknownNCT02389686
What this trial is testing

Intra-operative Radiotherapy For Breast Cancer Women After NSM

Who this might be right for
Breast Neoplasms
Liao Ning 110
Large-scale testing (Phase 3)Study completedNCT00072462
What this trial is testing

Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ

Who this might be right for
Breast Cancer
Queen Mary University of London 2,980
Early research (Phase 1)Study completedNCT01372644
What this trial is testing

Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial

Who this might be right for
Atypical Ductal Breast HyperplasiaLobular Carcinoma in Situ (LCIS)Atypical Lobular Hyperplasia (ALH) of Breast
NYU Langone Health 15
Next Page